The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

Canadian research suggests recommendations against screening for prostate cancer has led to a rise in the rates of stage 4 ...

The Prostate Cancer Foundation (PCF) is proud to announce the launch of an interactive website and downloadable guide, Somatic and Germline Genetic Testing for Patients with Advanced Prostate ...

Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.

Official recommendations that discourage use of hotly debated screening test could be linked to increase, experts suggest ...

ORLANDO, Fla. (Ivanhoe Newswire) - Prostate cancer is the second leading cause of death in men right behind heart disease. Patients with this cancer often don’t find out until the disease has advanced ...

The new recommendation from the UK NSC, which is subject to consultation, is for a targeted screening programme every two ...

The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the ...